Open Access

Time to act: what if your patient is in need of a different strategy following a worsening heart failure event?

Event: ESC Congress 2022
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session type: Satellite Symposium
sponsored by Bayer AG
Date: 28 August 2022
Time: 15:30 - 16:15

Congress Session

6 presentations in this session

Welcome and introduction.

Speaker: Professor C. Lam (Singapore, SG)
Thumbnail

What if... your patient has experienced a worsening HF event?

Speaker: Professor F. Ruschitzka (Zurich, CH)
Thumbnail

What if... you have decided to prescribe vericiguat for your patient?

Speaker: Professor B. Pieske (Berlin, DE)
Thumbnail

What if... your patient is unable to tolerate existing HFrEF therapies?

Speaker: Doctor S. Zieroth (Winnipeg, CA)
Thumbnail

Audience Q&A.

Thumbnail

Closing remarks.

Speaker: Professor C. Lam (Singapore, SG)
Thumbnail

5 speakers from this session

Professor Carolyn Sp Lam

Duke-NUS Medical School, Singapore (Singapore)
105 presentations
22 followers

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
82 presentations
4 followers

Professor Burkert Pieske

Charite University Hospital, Berlin (Germany)
50 presentations
2 followers

Doctor Shelley Zieroth

St. Boniface Hospital, Winnipeg (Canada)
23 presentations
2 followers

Professor Carolyn Sp Lam

Duke-NUS Medical School, Singapore (Singapore)
105 presentations
22 followers

This platform is supported by

logo Novo Nordisk